Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Intravenous Immunoglobulin (IVIg) Market Size Analysis from 2022 to 2027

1.5.1 Global Intravenous Immunoglobulin (IVIg) Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Intravenous Immunoglobulin (IVIg) Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Intravenous Immunoglobulin (IVIg) Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Intravenous Immunoglobulin (IVIg) Industry Impact

Chapter 2 Global Intravenous Immunoglobulin (IVIg) Competition by Types, Applications, and Top Regions and Countries

2.1 Global Intravenous Immunoglobulin (IVIg) (Volume and Value) by Type

2.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption and Market Share by Type (2016-2021)

2.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2016-2021)

2.2 Global Intravenous Immunoglobulin (IVIg) (Volume and Value) by Application

2.2.1 Global Intravenous Immunoglobulin (IVIg) Consumption and Market Share by Application (2016-2021)

2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2016-2021)

2.3 Global Intravenous Immunoglobulin (IVIg) (Volume and Value) by Regions

2.3.1 Global Intravenous Immunoglobulin (IVIg) Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Intravenous Immunoglobulin (IVIg) Consumption by Regions (2016-2021)

4.2 North America Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

4.10 South America Intravenous Immunoglobulin (IVIg) Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Intravenous Immunoglobulin (IVIg) Market Analysis

5.1 North America Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

5.1.1 North America Intravenous Immunoglobulin (IVIg) Market Under COVID-19

5.2 North America Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

5.3 North America Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

5.4 North America Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

5.4.1 United States Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

5.4.2 Canada Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

5.4.3 Mexico Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 6 East Asia Intravenous Immunoglobulin (IVIg) Market Analysis

6.1 East Asia Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

6.1.1 East Asia Intravenous Immunoglobulin (IVIg) Market Under COVID-19

6.2 East Asia Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

6.3 East Asia Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

6.4 East Asia Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

6.4.1 China Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

6.4.2 Japan Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

6.4.3 South Korea Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 7 Europe Intravenous Immunoglobulin (IVIg) Market Analysis

7.1 Europe Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

7.1.1 Europe Intravenous Immunoglobulin (IVIg) Market Under COVID-19

7.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

7.3 Europe Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

7.4 Europe Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

7.4.1 Germany Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.2 UK Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.3 France Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.4 Italy Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.5 Russia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.6 Spain Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.7 Netherlands Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.8 Switzerland Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

7.4.9 Poland Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 8 South Asia Intravenous Immunoglobulin (IVIg) Market Analysis

8.1 South Asia Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

8.1.1 South Asia Intravenous Immunoglobulin (IVIg) Market Under COVID-19

8.2 South Asia Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

8.3 South Asia Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

8.4 South Asia Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

8.4.1 India Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

8.4.2 Pakistan Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Analysis

9.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

9.1.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Under COVID-19

9.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

9.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

9.4 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

9.4.1 Indonesia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.2 Thailand Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.3 Singapore Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.4 Malaysia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.5 Philippines Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.6 Vietnam Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

9.4.7 Myanmar Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 10 Middle East Intravenous Immunoglobulin (IVIg) Market Analysis

10.1 Middle East Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

10.1.1 Middle East Intravenous Immunoglobulin (IVIg) Market Under COVID-19

10.2 Middle East Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

10.3 Middle East Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

10.4 Middle East Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

10.4.1 Turkey Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.3 Iran Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.5 Israel Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.6 Iraq Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.7 Qatar Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.8 Kuwait Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

10.4.9 Oman Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 11 Africa Intravenous Immunoglobulin (IVIg) Market Analysis

11.1 Africa Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

11.1.1 Africa Intravenous Immunoglobulin (IVIg) Market Under COVID-19

11.2 Africa Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

11.3 Africa Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

11.4 Africa Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

11.4.1 Nigeria Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

11.4.2 South Africa Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

11.4.3 Egypt Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

11.4.4 Algeria Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

11.4.5 Morocco Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 12 Oceania Intravenous Immunoglobulin (IVIg) Market Analysis

12.1 Oceania Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

12.2 Oceania Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

12.3 Oceania Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

12.4 Oceania Intravenous Immunoglobulin (IVIg) Consumption by Top Countries

12.4.1 Australia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

12.4.2 New Zealand Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 13 South America Intravenous Immunoglobulin (IVIg) Market Analysis

13.1 South America Intravenous Immunoglobulin (IVIg) Consumption and Value Analysis

13.1.1 South America Intravenous Immunoglobulin (IVIg) Market Under COVID-19

13.2 South America Intravenous Immunoglobulin (IVIg) Consumption Volume by Types

13.3 South America Intravenous Immunoglobulin (IVIg) Consumption Structure by Application

13.4 South America Intravenous Immunoglobulin (IVIg) Consumption Volume by Major Countries

13.4.1 Brazil Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.2 Argentina Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.3 Columbia Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.4 Chile Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.5 Venezuela Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.6 Peru Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

13.4.8 Ecuador Intravenous Immunoglobulin (IVIg) Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business

14.1 Baxter

14.1.1 Baxter Company Profile

14.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Specification

14.1.3 Baxter Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 CNBG

14.2.1 CNBG Company Profile

14.2.2 CNBG Intravenous Immunoglobulin (IVIg) Product Specification

14.2.3 CNBG Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Octapharma

14.3.1 Octapharma Company Profile

14.3.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Specification

14.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Grifols

14.4.1 Grifols Company Profile

14.4.2 Grifols Intravenous Immunoglobulin (IVIg) Product Specification

14.4.3 Grifols Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Hualan Bio

14.5.1 Hualan Bio Company Profile

14.5.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Specification

14.5.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 CSL

14.6.1 CSL Company Profile

14.6.2 CSL Intravenous Immunoglobulin (IVIg) Product Specification

14.6.3 CSL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 CBPO

14.7.1 CBPO Company Profile

14.7.2 CBPO Intravenous Immunoglobulin (IVIg) Product Specification

14.7.3 CBPO Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Kedrion

14.8.1 Kedrion Company Profile

14.8.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Specification

14.8.3 Kedrion Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Biotest

14.9.1 Biotest Company Profile

14.9.2 Biotest Intravenous Immunoglobulin (IVIg) Product Specification

14.9.3 Biotest Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Shanghai RAAS

14.10.1 Shanghai RAAS Company Profile

14.10.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Specification

14.10.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 LFB Group

14.11.1 LFB Group Company Profile

14.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Specification

14.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 BPL

14.12.1 BPL Company Profile

14.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Specification

14.12.3 BPL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Sichuan Yuanda Shuyang

14.13.1 Sichuan Yuanda Shuyang Company Profile

14.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Specification

14.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Intravenous Immunoglobulin (IVIg) Market Forecast (2022-2027)

15.1 Global Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Intravenous Immunoglobulin (IVIg) Value and Growth Rate Forecast (2022-2027)

15.2 Global Intravenous Immunoglobulin (IVIg) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Intravenous Immunoglobulin (IVIg) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Intravenous Immunoglobulin (IVIg) Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Intravenous Immunoglobulin (IVIg) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast by Type (2022-2027)

15.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027)

15.3.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)

15.4 Global Intravenous Immunoglobulin (IVIg) Consumption Volume Forecast by Application (2022-2027)

15.5 Intravenous Immunoglobulin (IVIg) Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology